Press Releases Evotec SE

Equities

EVT

DE0005664809

Biotechnology & Medical Research

Real-time Estimate Tradegate Other stock markets 08:01:52 06/03/2026 pm IST			5-day change	1st Jan Change
5.367 ^EUR	-1.78%		-8.47%	-1.61%

24/02	Centauri Therapeutics Limited announced that it has received £30 million in funding from a group of investors	CI
03/02	Evotec Shares Surge Following Berenberg Buy Recommendation	DP

Press Releases

05/03	Evotec : Current Company Presentation 1 MB (2026 03 EVT Company Presentation)	PU
30/01	Evotec SE: Dr. Cord Dohrmann, Disposal of 3653 shares (Sell-to-cover)	EQ
30/01	Evotec SE: Dr. Cord Dohrmann, Acquisition of 6760 shares due to vesting (Share Performance Plan 2017)	EQ
30/01	Evotec : Current Company Presentation 1 MB (2026 02 EVT Company Presentation)	PU
27/01	Evotec : English Code of Ethics and Business Conduct 2024 1.584 MB	PU
19/01	Evotec : Presentation (2025 11 05 EVT 9M Analyst Calll)	PU
08/01	Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access	EQ
06/01	Evotec : Declaration of Compliance with the German Corporate Governance Code for the year 2025 (December 2025) 51.097 KB	PU
01/01	Evotec : Current Company Presentation 999.321 KB (2026 01 EVT Company Presentation)	PU
01/01	Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations	EQ
09/12	Evotec SE: Prof. Dr. Iris Löw-Friedrich, buy	EQ
08/12	Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz	EQ
04/12	Evotec-partner Bayer starts Phase 2 study for treatment of patients with Alport syndrome	EQ
03/12	Evotec : Current Company Presentation 999.568 KB (2025 12 EVT Company Presentation)	PU
17/11	CMS: Evotec SE: Release of a capital market information	EQ
14/11	DD: Evotec SE: Aurélie Dalbiez, buy	EQ
14/11	DD: Evotec SE: Dr. Cord Dohrmann, sell	EQ
13/11	DD: Evotec SE: Dr. Cord Dohrmann, sell	EQ
13/11	DD: Evotec SE: Wesley Wheeler, buy	EQ
12/11	Evotec receives milestone payment from Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership	EQ
07/11	Evotec : Current Company Presentation 1.062 MB (2025 11 EVT Company Presentation)	PU
06/11	Evotec : Initial Announcement Share Buy Back Program - 06 November 2025 67.403 KB	PU
06/11	CMS: Evotec SE: Release of a capital market information	EQ
05/11	Evotec : Presentation (2025 11 05 EVT 9M Analyst Call)	PU
05/11	Evotec SE reports 9M 2025 results: Continued strong execution on strategic priorities	EQ